The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Assessment of Myocardial Scarring Improves Risk Stratification in Patients Evaluated for Cardiac Defibrillator Implantation
Open accessAbstract
Objectives We tested whether an assessment of myocardial scarring by cardiac magnetic resonance (CMR) would improve risk stratification in patients evaluated for implantable cardioverter-defibrillator implantation. Background Current SCD risk stratification emphasizes left-ventricular ejection fraction (LVEF), however the majority of patients suffering SCD have a preserved LVEF and many with poor LVEF do not benefit from ICD prophylaxis. Methods One hundred thirty-seven patients undergoing evaluation for possible ICD placement were prospectively enrolled and underwent CMR assessment of LVEF and scar. The prespecified primary endpoint was death or appropriate ICD discharge for sustained ventricular tachyarrhythmia. Results During a median follow-up of 24 months the primary endpoint occurred in 39 patients. Whereas the rate of adverse events steadily increased with decreasing LVEF, a sharp step-up was observed for scar size >5% of LV mass (HR=5.2 [95% CI, 2.0-13.3]). On multivariable Cox proportional hazards analysis, including LVEF and electrophysiological-study results, scar size (as a continuous variable or dichotomized at 5%) was an independent predictor of adverse outcome. Among patients with LVEF >30%, those with significant scarring (>5%) had higher risk than those with minimal-or-no (≤5%) scarring (HR=6.3 [1.4-28.0]). Those with LVEF >30% and significant scarring had similar risk to patients with LVEF ≤30% (p=0.56). Among patients with LVEF ≤30%, those with significant scarring again had higher risk than those with minimal-or-no scarring (HR=3.9 [1.2-13.1]). Those with LVEF ≤30% and minimal scarring had similar risk to patients with LVEF >30% (p=0.71). Conclusions Myocardial scarring detected by CMR is an independent predictor of adverse outcome in patients being considered for ICD placement. In patients with LVEF >30%, significant scarring (>5% LV) identifies a high-risk cohort similar in risk to those with LVEF ≤30%. Conversely, in patients with LVEF ≤30%, minimal-or-no scarring identifies a low-risk cohort similar to those with LVEF >30%.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging:, Cerqueira, M. D., Weissman, N. J., Dilsizian, V., Jacobs, A. K., Kaul, S., Laskey, W. K., Pennell, D. J., Rumberger, J. A., Ryan, T., et al. (2002) · Circulation · doi:10.1161/hc0402.102975 · Cited by 6,990
Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,902
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Kim, R. J., Wu, E., Rafael, A., Chen, E.-L., Parker, M. A., Simonetti, O., Klocke, F. J., Bonow, R. O., & Judd, R. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432003 · Cited by 3,306
Self-citationRosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., Haase, N., Ho, M., Howard, V., Kissela, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179918 · Cited by 3,277
Kim, R. J., Fieno, D. S., Parrish, T. B., Harris, K., Chen, E.-L., Simonetti, O., Bundy, J., Finn, J. P., Klocke, F. J., & Judd, R. M. (1999) · Circulation · doi:10.1161/01.cir.100.19.1992 · Cited by 2,581
Self-citationCardiac Electrophysiology: From Cell to Bedside
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-12-1069_5 · Cited by 2,385
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy
Kadish, A., Dyer, A., Daubert, J. P., Quigg, R., Estes, N. A. M., Anderson, K. P., Calkins, H., Hoch, D., Goldberger, J., Shalaby, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033088 · Cited by 2,080
Oss, J. M., Areba, W. O. Z., Ackson, W. J., Lein, H. E. K., Ilber, D. A. J. W., Annom, D. A. S. C., Ames, J. M., Aubert, P., Iggins, S. T. L. H., Rown, M. A. W. B., et al. (2002) · Cited by 2,027
Cited by
The Diagnosis and Evaluation of Dilated Cardiomyopathy
Japp, A. G., Gulati, A., Cook, S. A., Cowie, M. R., & Prasad, S. K. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.590 · Cited by 554
Heart failure with mid-range or mildly reduced ejection fraction
Savarese, G., Stolfo, D., Sinagra, G., & Lund, L. H. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00605-5 · Cited by 476
Arevalo, H. J., Vadakkumpadan, F., Guallar, E., Jebb, A., Malamas, P., Wu, K. C., & Trayanova, N. A. (2016) · Nature Communications · doi:10.1038/ncomms11437 · Cited by 465
Di Marco, A., Anguera, I., Schmitt, M., Klem, I., Neilan, T. G., White, J. A., Sramko, M., Masci, P. G., Barison, A., Mckenna, P., et al. (2017) · JACC: Heart Failure · doi:10.1016/j.jchf.2016.09.017 · Cited by 422
Self-citationFallavollita, J. A., Heavey, B. M., Luisi, A. J., Michalek, S. M., Baldwa, S., Mashtare, T. L., Hutson, A. D., deKemp, R. A., Haka, M. S., Sajjad, M., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.096 · Cited by 399
Kuruvilla, S., Adenaw, N., Katwal, A. B., Lipinski, M. J., Kramer, C. M., & Salerno, M. (2014) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.113.001144 · Cited by 387
Halliday, B. P., Gulati, A., Ali, A., Guha, K., Newsome, S., Arzanauskaite, M., Vassiliou, V. S., Lota, A., Izgi, C., Tayal, U., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.026910 · Cited by 384
Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease
Gourdie, R. G., Dimmeler, S., & Kohl, P. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.89 · Cited by 332
Disertori, M., Rigoni, M., Pace, N., Casolo, G., Masè, M., Gonzini, L., Lucci, D., Nollo, G., & Ravelli, F. (2016) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2016.01.033 · Cited by 331
Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy
Patel, A. R., & Kramer, C. M. (2017) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2017.08.005 · Cited by 313
Buss, S. J., Breuninger, K., Lehrke, S., Voss, A., Galuschky, C., Lossnitzer, D., Andre, F., Ehlermann, P., Franke, J., Taeger, T., et al. (2015) · European Heart Journal – Cardiovascular Imaging · doi:10.1093/ehjci/jeu181 · Cited by 262
Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy
Goldberger, J. J., Subačius, H., Patel, T., Cunnane, R., & Kadish, A. H. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.12.021 · Cited by 237
Stirrat, J., & White, J. A. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.11.033 · Cited by 33
Dilated Cardiomyopathy: From Genetics to Clinical Management
(2019) · doi:10.1007/978-3-030-13864-6 · Cited by 32
Metadata
- Authors
- Klem, I., Weinsaft, J. W., Bahnson, T. D., Hegland, D., Kim, H. W., Hayes, B., Parker, M. A., Judd, R. M., & Kim, R. J.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 60
- Issue
- 5
- Pages
- 408-420
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2091415389
- Cited by
- 331
- References
- 55
- FWCI
- 21.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.